Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort

[1] Smolen JS(2014)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Ann Rheum Dis 73 492-509

[2] Landewé R(2003)Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann Rheum Dis 62 120-6

[3] Breedveld FC(2013)The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis Cytokine 63 81-90

[4] Buch M(2003)Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice Nat Immunol 4 255-60

[5] Burmester G(2000)Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression J Exp Med 191 1095-104

[6] Dougados M(2007)Apo2L/TRAIL and immune regulation Front Biosci J Virtual Libr 12 2074-84

[7] Meyer O(2005)Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt J Biol Chem 280 15709-18

[8] Labarre C(1999)A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function Biochem Biophys Res Commun 256 449-55

[9] Dougados M(2003)Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice Arthritis Rheum 48 2042-51

[10] Goupille P(2014)A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis Arthritis Res Ther 16 R108-9

[1] Smolen JS(2014)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Ann Rheum Dis 73 492-509

[2] Landewé R(2003)Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann Rheum Dis 62 120-6

[3] Breedveld FC(2013)The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis Cytokine 63 81-90

[4] Buch M(2003)Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice Nat Immunol 4 255-60

[5] Burmester G(2000)Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression J Exp Med 191 1095-104

[6] Dougados M(2007)Apo2L/TRAIL and immune regulation Front Biosci J Virtual Libr 12 2074-84

[7] Meyer O(2005)Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt J Biol Chem 280 15709-18

[8] Labarre C(1999)A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function Biochem Biophys Res Commun 256 449-55

[9] Dougados M(2003)Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice Arthritis Rheum 48 2042-51

[10] Goupille P(2014)A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis Arthritis Res Ther 16 R108-9